Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Boorjian · SciRah

Researcher profile · Semantic Scholar

S. Boorjian

Share profile

S. Boorjian — researcher profile on SciRah

h-index: 12
Works: 165
Citations: 671

Most-cited papers

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial
Vikram M. Narayan, S. Boorjian, M. Alemozaffar, Badrinath R. Konety +36 more
2024Journal of Urology67 citations Open access
Semantic Scholar
Enhancing Accuracy of Operative Reports with Automated Artificial Intelligence Analysis of Surgical Video.
A. Khanna, T. Wolf, Igor Frank, A. Krueger +6 more
2025Journal of the American College of Surgeons24 citations
Semantic Scholar
Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter Analysis.
Daniel S. Roberson, Vidit Sharma, S. Boorjian, Matthew T. McLeay +12 more
2025European Urology12 citations
Semantic Scholar
Cost-Effectiveness of Trimodal Therapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
Daniel D. Joyce, K. Wymer, John A. Graves, S. Boorjian +6 more
2025JAMA Network Open7 citations Open access
Semantic Scholar
Refining BCG‐failure classifications in non‐muscle‐invasive bladder cancer
A. Ślusarczyk, P. Scilipoti, R. Contieri, Wojciech Krajewski +26 more
2026BJU International6 citations
Semantic Scholar
A Simplified Prediction Tool for Metastasis after Nephrectomy with Venous Tumor Thrombectomy for RCC.
Daniel S. Roberson, S. Basourakos, J. Cheville, Carlos A. Rivera López +11 more
2026Urology5 citations
Semantic Scholar
ABLE-22: Safety and efficacy evaluation of nadofaragene firadenovec alone or in combination with chemotherapy or immunotherapy—A randomized, open-label, phase 2 study.
S. Daneshmand, S. Boorjian, Joshua J. Meeks, T. Bivalacqua +7 more
2025Journal of Clinical Oncology5 citations
Semantic Scholar
The Film Room: Using Artificial Intelligence to Facilitate Video Review for Urology Trainees.
Grant M. Henning, Bridget L. Findlay, Tal D. Cohen, A. Potretzke +7 more
2024Journal of Surgical Education5 citations
Semantic Scholar
Impact of obesity on prostatectomy outcomes: Insights from a large prospectively maintained cohort.
Ekamjit S. Deol, Kelly Lehner, Anthony Fadel, L. Rangel +7 more
2025Urologic oncology4 citations Open access
Semantic Scholar
Real-world outcomes of nadofaragene firadenovec in BCG-unresponsive non-muscle invasive bladder cancer.
Jacob A. Moyer, A. Durant, Mimi Nguyen, Lanyu Mi +5 more
2025Journal of Clinical Oncology3 citations Open access
Semantic Scholar
Characterizing the hospital caseload-outcome relationship for radical nephrectomy with inferior vena cava tumor thrombectomy: analysis from the National Inpatient Sample.
Grant M. Henning, Ekamjit S. Deol, R. Vasdev, S. Basourakos +6 more
2025Urology3 citations
Semantic Scholar
Trends in Outpatient Radical Prostatectomy and Same-Day Discharge for Prostate Cancer: Analysis of the National Inpatient Sample and Nationwide Ambulatory Surgery Sample
Grant M. Henning, Ekamjit S. Deol, R. Vasdev, S. Basourakos +8 more
2025Urology Practice3 citations
Semantic Scholar
Renal Cell Carcinoma with Venous Tumor Thrombus Has a Predilection for the Lungs.
Reza Nabavizadeh, R. Pessoa, J. Cheville, C. Lohse +6 more
2024Urology3 citations
Semantic Scholar
Oncologic and survival outcomes in patients undergoing radical nephroureterectomy with preoperative or iatrogenic dialysis dependence.
Matthew S. Lee, P. Hensley, Dan Igel, Roger Li +12 more
2025Urologic oncology2 citations
Semantic Scholar
Level setting: a history and illustrative clarification of the Mayo Clinic tumour thrombus levels
Daniel S. Roberson, S. Boorjian, Vidit Sharma, B. Leibovich
2025BJU International2 citations
Semantic Scholar
Real-World Outcomes of Nadofaragene Firadenovec for BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer: A Multicenter Experience
Jacob A. Moyer, Lanyu Mi, Mimi V. Nguyen, A. Durant +5 more
2025Urologic oncology2 citations Open access
Semantic Scholar
Intravesical interferon-α2b gene therapy with nadofaragene firadenovec-vncg: a contemporary review.
Taeweon Lee, A. Gianchandani, S. Boorjian, N. Shore +3 more
2025Future Oncology2 citations Open access
Semantic Scholar
Comparative Effectiveness of Intravesical Gemcitabine vs Sequential Gemcitabine and Docetaxel for High-Risk Non–Muscle-Invasive Bladder Cancer
Jacob A. Moyer, M. Ashraf, Lanyu Mi, Andrew J. Zganjar +4 more
2026Urologic oncology1 citations Open access
Semantic Scholar
Comparative Assessment of Chemotherapy Followed by Consolidative Radical Cystectomy Versus Chemoradiation for Clinically Node-Positive Urothelial Carcinoma of the Bladder.
A. Ślusarczyk, P. Scilipoti, R. Contieri, Mattia Longoni +12 more
2025Clinical Genitourinary Cancer1 citations Open access
Semantic Scholar
The impact of prophylactic incisional negative pressure wound therapy on surgical site infection following open radical cystectomy.
Daniel S. Roberson, Matthew T. McLeay, Grant M. Henning, Gianni Morales-Martinez +8 more
2025Urologic oncology1 citations
Semantic Scholar
Use of Rectal Diazepam to Prevent Bladder Spasms and Leakage of Medication During Intravesical Administration of Nadofaragene Firadenovec for BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer
Jacob A. Moyer, A. Durant, Mimi V. Nguyen, Lanyu Mi +5 more
2025Journal of Urology1 citations
Semantic Scholar
Gender Authorship Among Urology Artificial Intelligence Publications: A 10-Year Retrospective Analysis.
G. Murray, R. Vasdev, Luqman M Ellythy, Tianyu He +7 more
2025Urology1 citations
Semantic Scholar
A Step Toward Modernization of Urologic Training: Incorporation of a Novel Surgical Intelligence Platform for Robotic Prostatectomy Video Review
Grant M. Henning, Bridget L. Findlay, Tal D. Cohen, Matthew T. McLeay +8 more
2025Journal of endourology1 citations
Semantic Scholar
Accuracy of 18F-FDG PET in Early Metastatic Testicular Seminoma: Analysis from the SEMS Trial.
Brian Hu, M. Alsyouf, Ala'a Farkouh, C. Cary +18 more
2025Journal of Urology1 citations
Semantic Scholar
The Impact of Open Surgical Team Consistency on Oncologic and Functional Outcomes Following Radical Prostatectomy.
Francis A. Jefferson, S. Boorjian, P. Thapa, M. Tollefson +5 more
2025Mayo Clinic proceedings1 citations
Semantic Scholar
Growth Kinetics of Venous Tumor Thrombus from Renal Cell Carcinoma.
Matthew T. McLeay, Daniel S. Roberson, Maddy Dorr, Gianni Morales-Martinez +8 more
2025Journal of Urology1 citations
Semantic Scholar
IP83-16 LONG-TERM ONCOLOGIC AND PATIENT-REPORTED QUALITY OF LIFE OUTCOMES OF PARTIAL CYSTECTOMY FOR UROTHELIAL CARCINOMA: A WORTHWHILE BLADDER PRESERVATION MODALITY
Chloe Shi, G. Martinez, Austin Martin, Cameron J. Britton +8 more
2026Journal of Urology0 citations
Semantic Scholar
CAST-AI: Cystectomy after systemic therapy with ADC and immunotherapy.
Jabra Zarka, E. Bering, Lynn M. Flickinger, Olivia J Bobek +16 more
2026Journal of Clinical Oncology0 citations Open access
Semantic Scholar
IP59-18 ARTIFICIAL INTELLIGENCE SEGMENTATION ALGORITHM FOR VENOUS TUMOR THROMBUS AMONG PATIENTS WITH RENAL CELL CARCINOMA PERFORMS COMPARABLY TO MANUAL HUMAN SEGMENTATION
E. Li, Matthew T. McLeay, Michael K. Wang, G. Michalak +6 more
2026Journal of Urology0 citations
Semantic Scholar
IP65-30 PERIOPERATIVE, ONCOLOGIC, AND FUNCTIONAL OUTCOMES FOLLOWING PARTIAL NEPHRECTOMY OR THERMAL ABLATION FOR RENAL ALLOGRAFT TUMORS
R. Vasdev, G. Murray, Vidit Sharma, A. Potretzke +5 more
2026Journal of Urology0 citations
Semantic Scholar
Cost-Effectiveness of Immune Checkpoint Inhibitor Therapy plus BCG for High-Risk Non-muscle Invasive Bladder Cancer: Analyses of CREST, POTOMAC, and ALBAN
Daniel D. Joyce, Vidit Sharma, Grace E. Ratcliff, D. Barocas +6 more
2026Journal of Urology0 citations Open access
Semantic Scholar
IP17-18 RADICAL PROSTATECTOMY VERSUS RADIATION WITH ANDROGEN DEPRIVATION THERAPY FOR CLINICAL LYMPH NODE POSITIVE PROSTATE CANCER: A CONTEMPORARY, SINGLE INSTITUTION SERIES WITH LANDMARK ANALYSIS
G. Murray, Alexandra Bennett, Jamie J. O'Byrne, Richard Choo +7 more
2026Journal of Urology0 citations
Semantic Scholar
Long-term Outcomes of Partial Cystectomy for Urothelial Carcinoma in the Era of Bladder Preservation.
Austin Martin, Chloe Shi, G. Martinez, Cameron J. Britton +8 more
2026Urology0 citations
Semantic Scholar
IP50-05 USING ARTIFICIAL INTELLIGENCE TO DISTINGUISH LOW GRADE UROTHELIAL CARCINOMA FROM BENIGN PATHOLOGY ON TURBT SURGICAL VIDEO
A. Khanna, K. Lifshitz, E. Li, Yariv Colbeci +10 more
2026Journal of Urology0 citations
Semantic Scholar
IP17-25 A CONTEMPORARY ANALYSIS OF POSITIVE SURGICAL MARGIN LENGTH AND ONCOLOGIC OUTCOMES AFTER RADICAL PROSTATECTOMY: RESULTS FROM AN INSTITUTIONAL REGISTRY WITH LONG-TERM FOLLOW UP
Chloe Shi, E. Li, Michael K. Wang, Jamie T. O'Byrne +9 more
2026Journal of Urology0 citations
Semantic Scholar
IP05-02 RADIOMIC TUMOR CONTACT SURFACE AREA PREDICTS POST-OPERATIVE COMPLICATIONS AND LOCAL RECURRENCE OUTCOMES FOR PATIENTS UNDERGOING MULTIFOCAL PARTIAL NEPHRECTOMY
E. Li, Michael K. Wang, Madeline Dorr, G. Michalak +6 more
2026Journal of Urology0 citations
Semantic Scholar
IP40-05 CARDIOVASCULAR HEALTH IN RENAL CELL CARCINOMA: ANALYSIS OF A MODIFIED LIFE’S ESSENTIAL 8 SCORE
Chloe Shi, Madeline Dorr, Michael K. Wang, E. Li +8 more
2026Journal of Urology0 citations
Semantic Scholar
IP83-09 UPFRONT PERIOPERATIVE ENFORTUMAB VEDOTIN PLUS PEMBROLIZUMAB VERSUS RISK-ADAPTED ADJUVANT PEMBROLIZUMAB OR NIVOLUMAB: COST-EFFECTIVENESS ANALYSIS OF EMERGING SYSTEMIC THERAPIES FOR CISPLATIN-INELIGIBLE PATIENTS WITH LOCALIZED MUSCLE-INVASIVE BLADDER CANCER
Z. Su, Tyler S. Garman, Taibo Li, R. Chelluri +11 more
2026Journal of Urology0 citations
Semantic Scholar
IP68-23 NCCN RISK GROUPS DO NOT PREDICT ADVERSE PATHOLOGY OR ONCOLOGIC OUTCOMES AMONG PATIENTS WITH GRADE GROUP 1 PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY IN THE CONTEMPORARY MRI ERA
E. Li, Tae-Hee Kim, Michael K. Wang, Jamie T. O'Byrne +10 more
2026Journal of Urology0 citations
Semantic Scholar
Response of venous tumor thrombi in renal cell carcinoma to immune checkpoint inhibitor therapy: A multicenter retrospective cohort study.
Eric Li, Michael Wang, Madeline Dorr, Daniel S. Roberson +9 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
IP30-10 VENOUS TUMOR THROMBUS SHOULD BE ADDED TO CLINICAL AND PATHOLOGY T4 STAGING CRITERIA IN UPPER TRACT UROTHELIAL CARCINOMA
R. Vasdev, Matthew T. McLeay, Daniel S. Roberson, P. Thapa +6 more
2026Journal of Urology0 citations
Semantic Scholar
IP23-16 A PELVIC MRI FOR BIOCHEMICAL RECURRENCE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY STRATIFIES OUTCOMES FOR SALVAGE RADIATION VS OBSERVATION
Nancy Wei, Jamie J. O'Byrne, F. Mastroleo, Ryan M. Phillips +11 more
2026Journal of Urology0 citations
Semantic Scholar
IP04-30 MODERNIZATION OF A HISTORICAL PROSTATE CANCER REGISTRY USING ARTIFICIAL INTELLIGENCE: A TALE OF TWO LLMS
Michael K. Wang, Peter Galatowitsch, Julian Diaz-Cabo, Jamie J. O'Byrne +10 more
2026Journal of Urology0 citations
Semantic Scholar
IP36-22 PERIOPERATIVE AND ONCOLOGIC OUTCOMES OF CONSOLIDATIVE SURGERY FOR ADVANCED UROTHELIAL CARCINOMA FOLLOWING INDUCTION ENFORTUMAB VEDOTIN AND PEMBROLIZUMAB: A MULTICENTER EXPERIENCE
Daniel S. Roberson, Sarah P. Psutka, J. Meeks, Timothy N. Clinton +17 more
2026Journal of Urology0 citations
Semantic Scholar
IP35-11 INFLUENCE OF GLP1 RECEPTOR AGONIST ON BLADDER CANCER INCIDENCE AND OVERALL SURVIVAL, A PROPENSITY SCORE MATCHED ANALYSIS USING THE OPTUMLABS DATA WAREHOUSE
Michael K. Wang, E. Li, H. Heien, Paras H. Shah +5 more
2026Journal of Urology0 citations
Semantic Scholar
IP74-22 SAFETY, EFFICIENCY AND ENVIRONMENTAL IMPACT OF VIRTUAL AT-HOME CATHETER REMOVAL FOLLOWING ROBOTIC-ASSISTED RADICAL PROSTATECTOMY
R. Vasdev, Sierra N. Tolbert, A. Hamandi, I. Frank +8 more
2026Journal of Urology0 citations
Semantic Scholar
PD12-01 DOES PERINEURAL INVASION ON BIOPSY ADD PROGNOSTIC VALUE IN THE CONTEMPORARY MRI ERA? RESULTS FROM A LARGE INSTITUTIONAL COHORT
Michael K. Wang, E. Li, Tae-Hee Kim, Chloe Shi +10 more
2026Journal of Urology0 citations
Semantic Scholar
PD23-12 AN ARTIFICIAL INTELLIGENCE ALGORITHM CHARACTERIZES THE DETERIORATION OF BODY COMPOSITION FROM SYSTEMIC THERAPY FOR PATIENTS WITH ADVANCED PROSTATE CANCER
Chloe Shi, Nancy Wei, G. Martinez, Jamie T. O'Byrne +9 more
2026Journal of Urology0 citations
Semantic Scholar
IP56-21 COMPUTER VISION-BASED BODY COMPOSITION BIOMETRICS IS ASSOCIATED WITH EARLY COMPLICATIONS AFTER NEPHROURETERECTOMY
R. Vasdev, G. Ungerer, K. Jain, P. Thapa +11 more
2026Journal of Urology0 citations
Semantic Scholar
IP84-24 EXTRACELLULAR VESICLE-BOUND FRACTION OF KIDNEY INJURY MOLECULE 1 IS A PROMISING BLOOD-BASED MARKER OF CLEAR-CELL RENAL CELL CARCINOMA
Rubia Noori, Yohan Kim, Madeline Dorr, Danielle L. Leukam +5 more
2026Journal of Urology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Khanna×30
Invite
A. Khanna — researcher profile on SciRah
Vidit Sharma×25
Invite
Vidit Sharma — researcher profile on SciRah
M. Tollefson×15
Invite
M. Tollefson — researcher profile on SciRah
Paras H. Shah×14
Invite
Paras H. Shah — researcher profile on SciRah

×13

Invite

R. Karnes — researcher profile on SciRah

B. Leibovich×13

Invite

B. Leibovich — researcher profile on SciRah

Daniel S. Roberson×10

Invite

Daniel S. Roberson — researcher profile on SciRah

Invite

I. Frank — researcher profile on SciRah

Matthew T. Gettman×9

Invite

Matthew T. Gettman — researcher profile on SciRah

Invite

E. Li — researcher profile on SciRah

Matthew T. McLeay×8

Invite

Matthew T. McLeay — researcher profile on SciRah

A. Potretzke×8

Invite

A. Potretzke — researcher profile on SciRah